高度門脈腫瘍栓（Vp3/4）を伴う進行肝細胞癌に対してのソラフェニブ投与の治療成績
スポンサーリンク
概要
- 論文の詳細を見る
We investigated efficacy of sorafenib therapy for advanced hepatocellular carcinoma (HCC) with Vp3/4 portal vein tumor thrombosis. According to modified RECIST, the therapeutic responses in Vp0/2 group (n=30) were 8 PR, 14 SD and 8 PD cases, and while those in Vp3/4 group (n=11) were 5 PR, 2 SD and 4 PD cases. The response rates and cumulative progression rates were not significantly different between two groups. The cumulative survival rates in Vp3/4 group were significantly lower than those in Vp0/2 group. The deteriorations of Child-Pugh scores in Vp3/4 group were significantly higher than those in Vp0/2 group. The possibility of the deterioration of liver function should be kept in mind during sorafenib therapy for advanced HCC with Vp3/4.
論文 | ランダム
- 2.層序(III調査)(渡嘉敷村阿波連浦貝塚発掘調査報告)
- 1.調査に至る経過(III調査)渡嘉敷村阿波連浦貝塚発掘調査報告)
- II位置と環境(渡嘉敷村阿波連浦貝塚発掘調査報告)
- Iはじめに(渡嘉敷村阿波連浦貝塚発掘調査報告)
- (19) 2B2 : モジュール実装 (2. 会議の概要, MES 2001 報告, 第 11 回マイクロエレクトロニクスシンポジウム)